TP53 and breast cancer: However, in a recent study on basal-like breast cancers treated by neo-adjuvant chemotherapy using an alkylating agent (cyclophosphamide), all tumours harbouring a mutated p53 presented a complete pathological response to treatment (Bertheau et al, 2007).